Epstein-Barr Virus-associated Post-Transplant Lymphoproliferative Disorders presented as Interstitial Pneumonia; Successful Recovery with Rituximab

被引：14

作者：

Kunitomi, Akane ^{[1
]}

Arima, Nobuyoshi ^{[1
]}

Ishikawa, Takayuki ^{[2
]}

机构：

[1] Kitano Hosp, Tazuke Kofukai Med Res Inst 1, Dept Hematol, Osaka, Japan

[2] Kyoto Univ, Dept Hematol & Oncol, Grad Sch Med, Kyoto, Japan

来源：

HAEMATOLOGICA | 2007年 / 92卷 / 04期

关键词：

EBV; PTLD; rituximab; interstitial pneumonia;

D O I：

10.3324/haematol.11142

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We describe a patient that developed Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorders (PTLD), which presented as interstitial pneumonia. He had received allogeneic bone marrow transplantation for the treatment of acute myeloid leukemia 17 months before, when he developed hypoxemia requiring emergent admission. Chest computed tomography revealed pulmonary interstitial shadows, but neither hepatomegaly nor lymphadenopathy were detected. Bronchoscopy with lung biopsy revealed a lymphomatous proliferation of EBV-infected B cells. The interstitial pneumonia rapidly deteriorated, but improved dramatically after treatment with anti-CD20 monoclonal antibody (rituximab). This is the first report of a patient with lung EBV-PTLD that presented as interstitial pneumonia and was successfully treated with rituximab.

引用

页码：49 / 52

页数：4

共 17 条

[1] Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: Prognostic factors and long-term outcome [J].

Benkerrou, M ;

Jais, JP ;

Leblond, V ;

Durandy, A ;

Sutton, L ;

Bordigoni, P ;

Garnier, JL ;

Le Bidois, J ;

Le Deist, F ;

Blanche, S ;

Fischer, A .

BLOOD, 1998, 92 (09) :3137-3147

[2] Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders:: results of a prospective multicenter phase 2 study [J].

Choquet, S ;

Leblond, V ;

Herbrecht, R ;

Socié, G ;

Stoppa, AM ;

Vandenberghe, P ;

Fischer, A ;

Morschhauser, F ;

Salles, G ;

Feremans, W ;

Vilmer, E ;

Peraldi, MN ;

Lang, P ;

Lebranchu, Y ;

Oksenhendler, E ;

Garnier, JL ;

Lamy, T ;

Jaccard, A ;

Ferrant, A ;

Offner, F ;

Hermine, O ;

Moreau, A ;

Fafi-Kremer, S ;

Morand, P ;

Chatenoud, L ;

Berriot-Varoqueaux, N ;

Bergougnoux, L ;

Milpied, N .

BLOOD, 2006, 107 (08) :3053-3057

[3] First line therapy with fludarabine combinations in 42 patients with either post myelodysplastic syndrome or therapy related acute myeloid leukaemia [J].

Clavio, M ;

Gatto, S ;

Beltrami, G ;

Cerri, R ;

Carrara, P ;

Pierri, I ;

Canepa, L ;

Miglino, M ;

Balleari, E ;

Masoudi, B ;

Damasio, E ;

Ghio, R ;

Sessarego, M ;

Gobbi, M .

LEUKEMIA & LYMPHOMA, 2001, 40 (3-4) :305-313

[4] Increased incidence of EBV-related disease following paediatric stem cell transplantation with reduced-intensity conditioning [J].

Cohen, J ;

Gandhi, M ;

Naik, P ;

Cubitt, D ;

Rao, K ;

Thaker, U ;

Davis, EG ;

Gaspar, HB ;

Amrolia, PJ ;

Veys, P .

BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (02) :229-239

[5] POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER - INTRATHORACIC MANIFESTATIONS [J].

DODD, GD ;

LEDESMAMEDINA, J ;

BARON, RL ;

FUHRMAN, CR .

RADIOLOGY, 1992, 184 (01) :65-69

[6] Lymphocyte data in Epstein-Barr-virus induced post-transplant lymphoproliferative disorder treated by rituximab [J].

Entz-Werle, N ;

Cojean, N ;

Barats, A ;

Eyer, D ;

Munzer, M ;

Uring-Lambert, B ;

Falkenrodt, A ;

Babin, A ;

Lutz, P .

PEDIATRIC TRANSPLANTATION, 2003, 7 (04) :277-281

[7] Thoracic presentations of posttransplant lymphoproliferative disorders [J].

Halkos, ME ;

Miller, JI ;

Mann, KP ;

Miller, DL ;

Gal, AA .

CHEST, 2004, 126 (06) :2013-2020

[8] Post-transplant lymphoproliferative disorder: a review [J].

Loren, AW ;

Porter, DL ;

Stadtmauer, EA ;

Tsai, DE .

BONE MARROW TRANSPLANTATION, 2003, 31 (03) :145-155

[9] Pulmonary involvement in pediatric lymphoma [J].

Maturen, KE ;

Blane, CE ;

Strouse, PJ ;

Fitzgerald, JT .

PEDIATRIC RADIOLOGY, 2004, 34 (02) :120-124

[10] INFUSIONS OF DONOR LEUKOCYTES TO TREAT EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].

PAPADOPOULOS, EB ;

LADANYI, M ;

EMANUEL, D ;

MACKINNON, S ;

BOULAD, F ;

CARABASI, MH ;

CASTROMALASPINA, H ;

CHILDS, BH ;

GILLIO, AP ;

SMALL, TN ;

YOUNG, JW ;

KERNAN, NA ;

OREILLY, RJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (17) :1185-1191

← 1 2 →